+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era

AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era

Current Opinion in Oncology 19(5): 446-451

Effective antiretroviral therapy use has resulted in a large number of older individuals living with HIV. Recent literature is reviewed with respect to the incidence and risk factors for cancer in HIV patients. Previous studies have demonstrated substantial declines in AIDS-defining malignancies in the era of antiretroviral therapy, with clear links to better immune function. Increases in non-AIDS-defining malignancies such as Hodgkin's disease, skin, lung, anal, and kidney cancers have been noted by some but not all authors. Certain non-AIDS-defining malignancies may be related to immunodeficiency, although data are conflicting. Recent studies have indicated that confounding by traditional risk factors, including cigarette use, may account for some of the increased risk of lung and other cancers in HIV patients. Non-AIDS-defining malignancies account for more morbidity and mortality than AIDS-defining malignancies in the antiretroviral therapy era. Traditional risk factors play a significant role in the increased risk of non-AIDS-defining malignancies for HIV-infected individuals, but do not entirely explain the excess cancer risk. Unanswered questions remain including the relationship of immunodeficiency and the risk of site-specific non-AIDS-defining malignancies, and the effect of antiretroviral therapy duration and drug class on cancer risk.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051294434

Download citation: RISBibTeXText

PMID: 17762569

DOI: 10.1097/cco.0b013e3282c8c90d

Related references

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy. Aids 28(16): 2407-2415, 2015

Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy. Plos One 9(10): E111400, 2016

Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults. Aids Research and Human Retroviruses 31(5): 514-518, 2016

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clinical Infectious Diseases 48(8): 1138-1151, 2009

Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States. Aids Patient Care and Stds 24(5): 279-286, 2010

Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clinical Infectious Diseases 39(9): 1380-1384, 2004

Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Current Hiv/Aids Reports 5(3): 140-149, 2008

Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy. Recenti Progressi in Medicina 100(12): 547-549, 2010

Spectrum of AIDS defining & non-AIDS defining malignancies in north India. Indian Journal of Medical Research 143(Suppl.): S129-S135, 2017

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. Aids 22(16): 2143-2153, 2008

Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy. Aids Reviews 14(1): 3-16, 2012

Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clinical Infectious Diseases 52(12): 1458-1465, 2011

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. American Journal of Epidemiology 165(10): 1143-1153, 2007

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation. Journal of the International Aids Society 21(1), 2018

Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study. Annals of Internal Medicine 169(2): 87-96, 2018